Template:Antibacterial Spectra Key: Difference between revisions
(Created page with "*'''+''' usually effective clinically or >60% susceptible *'''+/-''' clinical trials lacking or 30-60% susceptible *'''0''' not effective clinically or <30% susceptible *'''bl...") |
No edit summary |
||
| Line 1: | Line 1: | ||
*''' | *'''S''' susceptible/sensitive (usually) | ||
*'''+ | *'''I''' intermediate (variably susceptible/resistant) | ||
*''' | *'''R''' resistant (or not effective clinically) | ||
*''' | *'''S+''' synergistic with cell wall antibiotics | ||
*'''X1''' no data | |||
*'''X2''' active in vitro, but not used clinically | |||
*'''X3''' active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis | |||
*'''X4''' active in vitro, but not clinically effective for strep pneumonia | |||
Revision as of 06:25, 3 June 2014
- S susceptible/sensitive (usually)
- I intermediate (variably susceptible/resistant)
- R resistant (or not effective clinically)
- S+ synergistic with cell wall antibiotics
- X1 no data
- X2 active in vitro, but not used clinically
- X3 active in vitro, but not clinically effective for Group A strep pharyngitis or infections due to E. faecalis
- X4 active in vitro, but not clinically effective for strep pneumonia